Testim (testosterone) NDC 66887-001

NDC codes

FDA NDC Directory

Product NDC (as listed)66887-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66887-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66887-001-05	66887000105	30 TUBE in 1 CARTON (66887-001-05) / 5 g in 1 TUBEMarketed from Oct 31, 2002

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Testim
Generic name (nonproprietary): testosterone
Active ingredients: Testosterone — 50 mg/5g
Dosage form: Gel
Route: Transdermal
Labeler: Endo USA, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021454
Marketing start: Oct 31, 2002
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 66887-001_366a5e88-4a23-46b0-94e5-e7f7deb7acbeSPL ID 366a5e88-4a23-46b0-94e5-e7f7deb7acbeSPL set ID 9f2aae1f-898d-4955-be31-678e0cf85395RxCUI 1597129, 1597132UNII 3XMK78S47O
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466887000105 followed by a unit qualifier and the quantity

Package 66887-0001-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

TESTIM is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituit…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)